NCT07641335

Brief Summary

This study will examine whether caffeine improves cognitive and competitive performance in professional chess players during tournament-style games. In a randomized double-blind crossover design, participants will complete two experimental sessions in which they consume either caffeinated coffee or decaffeinated coffee before playing a standardized chess match. Cognitive performance will be assessed using attention and reaction-time tests, including the Stroop Test, Trail Making Test, and Puzzle Rush task. Chess performance outcomes such as move accuracy, time management, and error rates will also be evaluated. The study aims to determine whether moderate caffeine intake enhances focus, alertness, and decision-making during prolonged competitive chess play.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
14mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 11, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

June 11, 2026

Status Verified

June 1, 2026

Enrollment Period

12 months

First QC Date

May 24, 2026

Last Update Submit

June 8, 2026

Conditions

Keywords

CaffeineChess PerformanceCognitive PerformanceAttentionMental FatigueProfessional Chess PlayersDecision MakingNeurocognitive PerformanceRandomized Crossover TrialCoffeeAlertnessExecutive FunctionCognitive Fatigue

Outcome Measures

Primary Outcomes (1)

  • Chess Performance Accuracy

    Chess performance accuracy will be assessed using engine-based analysis of tournament-style chess games. The primary reported metric will be average centipawn loss per move, with lower values indicating better chess performance accuracy.

    30 minutes after beverage consumption through completion of the tournament-style chess game at each experimental visit.

Secondary Outcomes (7)

  • Puzzle Rush Correct Responses

    Approximately 30 minutes after beverage consumption at each experimental visit.

  • Puzzle Rush Response Speed

    Approximately 30 minutes after beverage consumption at each experimental visit.

  • Stroop Test Performance

    Before gameplay and immediately after gameplay at each experimental visit.

  • Trail Making Test Performance

    Before gameplay and immediately after gameplay at each experimental visit.

  • Self-Reported Alertness

    Pre-game and immediately post-game at each experimental visit.

  • +2 more secondary outcomes

Study Arms (2)

Caffeinated Coffee

ACTIVE COMPARATOR

Participants will consume one serving of black caffeinated coffee prepared from 15 g of ground coffee brewed in 200 g of water, providing approximately 100 mg of caffeine. The beverage will be consumed approximately 30 minutes before completion of cognitive testing and a standardized tournament-style chess game during the experimental visit.

Dietary Supplement: Caffeinated Coffee

Decaffeinated Coffee Placebo

PLACEBO COMPARATOR

Participants will consume one serving of black decaffeinated coffee prepared to match the caffeinated coffee in taste and appearance. The beverage will be consumed approximately 30 minutes before completion of cognitive testing and a standardized tournament-style chess game during the experimental visit.

Dietary Supplement: Decaffeinated Coffee Placebo

Interventions

Caffeinated CoffeeDIETARY_SUPPLEMENT

Black caffeinated coffee prepared from 15 g of ground coffee brewed in 200 g of water, providing approximately 100 mg of caffeine. The beverage will be consumed approximately 30 minutes before cognitive testing and tournament-style chess gameplay.

Caffeinated Coffee

Black decaffeinated coffee prepared from the same batch of coffee beans and matched for taste and appearance to the caffeinated condition. The beverage will be consumed approximately 30 minutes before cognitive testing and tournament-style chess gameplay.

Decaffeinated Coffee Placebo

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female professional chess players aged 18-50 years
  • Current Fédération Internationale des Échecs (FIDE) standard rating between 2300 and 2600 Elo, or achievement of a standard FIDE rating within this range during the previous 12 months
  • Habitual caffeine consumers consuming ≤2 cups of coffee per day
  • Willingness to comply with all study procedures and study visits
  • Ability to provide written informed consent

You may not qualify if:

  • Non-caffeine users
  • Habitual caffeine intake exceeding 2 cups of coffee per day
  • Cardiovascular disorders
  • Metabolic disorders
  • Psychiatric disorders
  • Pregnancy or breastfeeding
  • Current smoking
  • Shift workers
  • Use of psychoactive medications
  • Participation in another clinical trial within the previous 3 months
  • Known allergy or intolerance to milk proteins, dairy products, or soy
  • Known red-green color blindness or other color vision deficiencies that may interfere with Stroop Test performance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Louis University

St Louis, Missouri, 63104, United States

Location

MeSH Terms

Conditions

Mental Fatigue

Condition Hierarchy (Ancestors)

FatigueSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Hossein Rafiei, PhD

    St. Louis University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The caffeinated and decaffeinated coffee beverages will be prepared and coded by a designated research team member who is not involved in participant testing, cognitive assessments, gameplay supervision, or outcome analysis. Participants, investigators, and outcome assessors will remain blinded to intervention assignment until completion of data analysis.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants will complete both intervention conditions in randomized order, including caffeinated coffee and decaffeinated coffee placebo. Each participant will serve as their own control in this double-blind crossover design. Experimental visits will be separated by a 3- to 7-day washout period to minimize potential carryover effects between conditions. During each visit, participants will complete standardized cognitive assessments and one tournament-style chess game under controlled laboratory conditions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 11, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

June 11, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared because this is a small pilot study involving highly specialized professional chess players, and there is potential risk of participant identification despite de-identification procedures.

Locations